The slip
PARKINSON RECEIPTno. 3972
20 Oct 2026, 07:03 UTCdopamine neurons, braak
predictionPICALM in dopamine neurons tracks Braak Lewy-body stage
registeredfc5ad690934a1701
discovery+0.12 p=0.767 n=9
replication-0.27 p=0.489 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.12, p 0.767)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTbb9065c8a96732f5e46d90b3…
follows b2df9d54554a…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 3972: PICALM in dopamine neurons, braak
- power
- full sample -0.03 (p 0.915, n 18), 95% CI -0.49 to +0.45. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.03 (p 0.908, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.21 (p 0.403, n 18). could be the mix.
- skeptic
- leave-one-out range -0.16 to +0.08, sign flips 5; without severely affected donors -0.03 (p 0.915, n 18). fragile.
- cell type
- strongest in OPCs: +0.62 (p 0.0057, n 18) vs -0.03 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PICALM in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up PICALM · OPCs · braak: substantia nigra, an independent cohort (already registered)